Osteoporosis Management In Women Who Had a Fracture (OMW)

The percentage of women 67–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the 180 days (6 months) after the fracture. 

Why It Matters

Osteoporosis is the most common metabolic bone disease and is characterized by low bone mineral density and structural deterioration of bone tissue, causing bone fragility and increasing the risk of fractures (1). 

Fragility fractures (fractures from falls from a standing position) are considered one of the most serious warning signs of osteoporosis or low bone density. Individuals who experience a fragility fracture have a 1.5-to 9.5-fold increased risk of further fracture (6). Osteoporosis related fractures can occur in the hip, vertebrae, shin, and other bones. Hip fractures have been linked to lower quality of life, increased mortality and a dependent living status (6). A review of the Health and Retirement Study (study period between 1992 and 2010) indicated that 27% of adults age 50 and older died 1 year after a hip fracture (7). 

Pharmacologic treatment can reduce the risk of subsequent fractures by 30%–50%. Unfortunately, testing and treatment for low bone mass after fracture has been shown to be as low as 20% (1). This and other research suggests a large opportunity for organizations to improve how well they manage women at an increased risk for fracture. The organization can improve its performance on this measure by both educating practitioners on follow-up care after fracture and by tracking administrative data for the occurrence of fracture and following up to ensure that appropriate care was provided. 

National Institutes of Health. Osteoporosis and Related Bone Diseases National Resource Center (NIH NIAMS). October 2019. “Osteoporosis: Overview.” 

Historical Results – National Averages

Get Access to the Historical Results

By completing the form below, you’ll gain free access to national performance data.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

References

  1. National Osteoporosis Foundation. 2015. Osteoporosis Fast Facts. https://cdn.nof.org/wp-content/uploads/2015/12/Osteoporosis-Fast-Facts.pdf
  2. Black, D.M., and C.J. Rosen. 2016. “Postmenopausal Osteoporosis.” New England Journal of Medicine 374(3), 254–62.
  3. Posen, J., D.E. Beaton, J. Sale, and E.R. Bogoch. 2013. “Bone Mineral Density Testing After Fragility Fracture: Informative Test Results Likely.” Canadian Family Physician 59(12), E564–71.
  4. Cenzer, I.S., V. Tang, W.J. Boscardin, A.K. Smith, C. Ritchie, M.I. Wallhagen, R. Espaldon, and K.E. Covinsky. 2016. “One‐Year Mortality After Hip Fracture: Development and Validation of a Prognostic Index.” Journal of the American Geriatrics Society 64(9), 1863–8.

  • Save
  • Email
  • Print